protein polymer to degraded subunit was much greater than in low-viscosity samples during infusion of pentagastrin alone. Over a period of time, endogenous pepsin split the glycoprotein polymer into subunits, and this was accompanied by a decrease in the viscosity of the juice. The increased viscosity with secretin infusion cannot be explained by a decrease in pepsin activity, since this doubled during the secretin infusion: also, the viscosity contribution from the pepsin was negligible.
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In conclusion, the mucus glycoprotein seen on infusion with pentagastrin alone is associated with predominately degraded glycoprotein subunits, and a low viscosity. This probably reflects the extra volume of gastric juice washing out previously degraded mucus from the stomach. With secretin, however, there is a large rise in the reduced and specific viscosity, and in the undegraded polymeric glycoprotein characteristic of the gel. This rise in undegraded glycoprotein in the juice, assuming no increase in mechanical erosion, is compatible with a genuine increase in mucus-gel secretion stimulated by secretin. These results also emphasize that measurements of the glycoprotein concentration or output in gastric juice alone cannot be directly equated with changes in the amount of the surface mucus gel. Several gastrointestinal hormones act on the liver, and in particular on bile flow (Forker, 1977) . Somatostatin decreases bile flow and bile acid excretion in the dog (Lin et al.. 1977; Holm et al., 1978) . The response is rapid and already significant at a dosage of 0.3pg/kg body wt. per h. As somatostatin inhibits gastrin-induced gastric secretion and secretin-induced pancreatic juice, Holm et al. (1978) have speculated that it might inhibit gut hormone-induced bile secretion, but the mechanism has not been elucidated. In anaesthetized rats somatostatin had no effect on bile flow, yet the effect was pronounced on the gastric acid output (Linscheer & Raheja, 1978) . In man also, somatostatin was reported not to affect biliary volume and bilirubin excretion (Raptis et al., 1978).
We have used two different experimental conditions in the rat to analyse the possible effect and the means of action of somatostatin on hepatocytic (canalicular) and ductular bile flow.
Male Wistar R rats weighing 300-35Og were used after they had fully recovered from anaesthesia (50mg of pentobarbital/kg body wt.) 3 h after surgical preparation of the bile duct and jugular vein when bile flow and composition are stable (Fevery et al., 1972) . In the first experimental condition different bile acid-secretion rates were obtained: 90 min. after operation group A (n = 7) received a continuous infusion of sodium taurocholate (1.5pmollkg body wt. per min) to compensate loss; group B (n = 7) received only normal saline (0.9% NaCI).
Collection of control bile started 90 rnin later. Group C (n = 6), receiving only saline, was tested 8 h after the preparation of the biliary drainage, to produce a marked decrease of bile flow and bile acid-secretion rate. In all experiments bile was collected in tared tubes over lOmin periods. The timing of the experiment comprised a 30min control period, a 60min somatostatin (Ayerst Laboratories: 20pg/kg body wt. per h; no priming dose) infusion and a 60min recovery stage. In the second condition only animals stabilized with a continuous infusion of sodium taurocholate, as in group A, were used. [''ClErythritol (The Radiochemical Centre, Amersham, Bucks., U.K.) was injected (3pCi as priming dose. followed by an infusion of O.OOBpCi/kg body wt. per rnin until the end of the experiment). Erythritol was allowed to equilibrate for 90 rnin before sampling of bile. Experimental animals (n = 7) received somatostatin for 60min as described above. Blood (300~1) was obtained through the carotid artery prepared surgically and kept open by a continuous injection of heparin (15 units/kg body wt. per h) in normal saline. It was taken at 15 and 5 rnin before, and at 35,45 and 55 rnin after, the onset of somatostatin infusion; samples at 65 and 75min after discontinuation of the infusion (recovery phase) were also obtained. Animals infused only with saline (n = 5 ) were used as controls (sham infusion).
The overall effect of somatostatin can be divided into two parts: an early phase, already significant at the end of the first IOmin, where the bile flow and bile acid output decreased progressively, and a steady state, from 30min to the end of the infusion. In the early phase the ratio of bile acid concen-' tration/bile flow remained unchanged. Further data refer only to the steady state, where the maximal display of the cholestatic action has been reached, to allow a quantitative analysis. Under all experimental conditions the bile flow was decreased by 27% compared with the control period, and returned to original values within 20-30 min after discontinuation of somatostatin treatment. Bile acid concentration was increased above the control value (23.1 f 6.3%; mean? s.E.M.) in group A, and showed no significant changes in groups B and C. Although the bile acid output was significantly decreased in the three groups (23.7f4.2% in group A; 41.8+4.9% in group B; 31.1 f 11.0% in group C; means f s.E.M.), the value of the ratio of bile acid concentration/bile flow was increased to different extents, suggesting that the water output was further diminished. The bile salt-independent bile flow, calculated as the intercept of the regression line of bile acid output plotted against bile flow, was decreased from 3.75 to 2.81pl/min per lOOg body wt., this decrease being about 17% of the total flow. In the second series of experiments, the clearance of erythritol, which is generally accepted as an estimate of the hepatocytic flow, was 4.46~11 lOOg body wt. per min during the control period either for test or for sham-infused animals. The total bile flow was 5.35p1/100g body wt. per min. The ratio of bile/plasma erythritol concentration was less than 1, which suggests dilution of the hepatocytic bile. It indicates the contribution from the addition of a further quantity of water, presumably bileduct secretion, to the hepatocytic flow. In the control periods of the present experiment, the overall ratio of bile/plasma erythritol concentration was 0.84 f 0.09 (mean f s.E.M.), suggesting that the 'ductular flow' represented less than 15.8% of the total flow. In somatostatin-treated animals, the ratio of bile/plasma erythritol concentration increased to 0.98 f 0.06 (mean f s.E.M.). This would suggest that the 'ductular flow' was practically abolished by somatostatin. In treated rats the bile flow decreased 24.7% and the erythritol clearance decreased 13.796, whereas in the sham-infused animals both parameters decreased 16.5 and 15.5% respectively. This difference again suggests that the 'ductular flow' was more decreased than the hepatocytic bile flow.
We conclude that somatostatin has at least two sites where it displays an effect on the bile flow. It affects the bile aciddependent fraction, and also the bile acid-independent bile flow. Of this second part, probably the whole ductular component is suppressed at the administered dosage.
We thank Professor K. P. M. Heirwegh Previous assays for enterokinase have relied on detecting trypsin formed after activation of trypsinogen. These methods have the advantage of sensitivity due to amplification in the enzymic assay of the trypsin; however, the activation is generally performed far from the optimal conditions for enterokinase activity to avoid autoactivation of the trypsinogen and cannot be performed in biological fluids containing trypsin inhibitors. We have developed a sensitive assay relying on detection of the other equimolar product of the activation, the activation peptide.
Bovine trypsinogen was purified by ion-exchange chromatography on CM-52 cellulose, and the side-chain lysine residues were protected by reaction with methyl acetimidate at pH 9.3 (Gamer & Gurd, 1975) . The protected derivative was labelled with [ ,H]acetic anhydride and deprotected by incubation in NH, (sp.gr. 0.88)/acetic acid, pH 11.3 (Ludwig & Byme, 1962) . The final labelled product was characterized by ion-exchange chromatography and both denaturing and non-denaturing polyacrylamide gel electrophoresis and was shown to behave essentially as the native zymogen.
Activation of the zymogen with enterokinase in the presence of the soya-bean trypsin inhibitor, or with trypsin, produced three labelled species migrating as activation peptides on highvoltage paper electrophoresis at pH6.5. Over 80% of the total label appears to be in these peptides. They are likely to be An assay for enterokinase has been developed with this substrate. Activation of the zymogen is allowed to proceed for 90min in the presence of soya-bean trypsin inhibitor at pH8.0 and 3OoC, with 7rnwCa2+, and after trichloracetic acid precipitation the soluble radioactivity is determined. The cleavage has been shown to be stimulated by Ca2+ up to 15 mM and by bile salt below the critical micellar concentration. It is inhibited by high ionic strength, specific antibody to human enterokinase and low-molecular-weight enterokinase inhibitors, but not by macromolecular proteinase inhibitors. Performing the reaction in the presence of soya-bean trypsin inhibitor has therefore allowed a re-evaluation of the kinetic parameters of the reaction at the optimal pH (8) and at high trypsinogen concentrations (up to 3mg/ml). From analysis of the kinetic data by the direct linear plot of Cornish-Bowden & Eisenthal (1974) , values of 9 7 . 5~~ for K,,, and 66 s-l for k,,,. were calculated.
Cleavage of the substrate in the absence of trypsin inhibitor had the characteristics of an autocatalytic process and was not greatly dependent on ionic strength or bile salt.
The assay for enterokinase is specific, sensitive and rapid and has allowed the detection of small quantities of the enzyme in blood, bile and other biological fluids as described in the following paper (Grant et al., 1980) 
